Determinants of late-onset heart failure in myocardial infarction survivors: GISSI prevenzione trial results;Determinantes de insuficiencia cardíaca tardía postinfarto de miocardio: Resultados del estudio GISSI Prevenzione

Revista Espanola de Cardiologia

Volumn 58, Issue 11, 2005, Pages 1266-1272

  Macchia, Alejandro ^a   Levantesi, Giacomo ^a   Marfisi, Rosa M ^a   Franzosi, Maria G ^b   Maggioni, Aldo P ^c   Nicolosi, Gian L ^d   Schweiger, Carlo ^e   Tavassi, Luigi ^f   Tognoni, Gianni ^a   Valagussa, Franco ^g   Marchioli, Roberto ^a  

^a Laboratorio Angela Valenti dei Fattori Genetici e Ambientali di Rischio Trombotico   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c ANMCO RESEARCH CENTER   (Italy)

^d S MARIA DEGLI ANGELI HOSPITAL   (Italy)

^e Civil Hospital   (Italy)

^f FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^g SAN GERARDO HOSPITAL   (Italy)

Author keywords

Heart failure; Myocardial infarction; Prognosis

Indexed keywords

ALPHA TOCOPHEROL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; POLYUNSATURATED FATTY ACID;

ADULT; AGE; AGED; ARTERY DISEASE; ARTICLE; CLINICAL TRIAL; COVARIANCE; DIABETES MELLITUS; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART RATE; HEART REINFARCTION; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; PATIENT SELECTION; PREDICTION; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE;

EID: 30044434004     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1885-5857(06)60413-1     Document Type: Article

References (16)

1. Danchin N, Urban P, De Benedetti E. Acute myocardial infarction. Clin Evid. 2003;10:37-63.
2. Guidry UC, Evans JC, Larson MG, Wilson PW, Murabito JM, Levy D. Temporal trends in event rates after Q-wave myocardial infarction: the Framingham Heart Study. Circulation. 1999;100: 2054-9.
3. Rosamond WD, Chambless LE, Folsom AR, Cooper LS, Conwill DE, Clegg L, et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med. 1998;339:861-7.
4. Roger VL, Jacobsen SJ, Weston SA, Goraya TY, Killian J, Reeder GS, et al. Trends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted County, Minnesota, 1979 to 1994. Ann Intern Med. 2002;136:341-8.
5. American Heart Association. Heart Disease and Stroke Statistics: 2005 Update. Dallas: American Heart Association; 2005.
6. Goldberg RJ, Konstam MA. Assessing the population burden from heart failure: need for sentinel population-based surveillance systems. Arch Intern Med. 1999;159:15-7.
7. Gheorghiade M, Bonow RO. Chronic heart failure in the United States. A manifestation of coronary artery disease. Circulation. 1998;97:282-9.
8. Hellermann JP, Jacobsen SJ, Gersh BJ, Rodeheffer RJ, Reeder GS, Roger VL. Heart failure after myocardial infarction: a review. Am J Med. 2002;113:324-30.
9. Lewis EF, Moye LA, Rouleau JL, Sacks FM, Arnold JM, Warnica JW, et al. Predictors of late development of heart failure in stable survivors of myocardial infarction. J Am Coll Cardiol. 2003;42:1446-53.
10. Hellermann JP, Jacobsen SJ, Redfield MM, Reeder GS, Weston SA, Roger VL. Heart failure after myocardial infarction: clinical presentation and survival. Eur J Heart Fail. 2005;7:119-25.
11. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet. 1999;354:447-55.
12. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE, et al. On behalf of the SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival And Ventricular Enlargement trial. N Engl J Med. 1992;327:669-77.
13. Every NR, Frederick PD, Robinson M, Sugarman J, Bowlby L, Barron HV. A comparison of the national registry of myocardial infarction 2 with the cooperative cardiovascular project. J Am Coll Cardiol. 1999;33:1886-94.
14. Assaf AR, Lapane KL, McKenney JL, Carleton RA. Possible influence of the prospective payment system on the assignment of discharge diagnoses for coronary heart disease. N Engl J Med. 1993;329:931-5.
15. Tavazzi L, Maggioni AP, Tognoni G. Participation versus education: The GISSI story and beyond. Am Heart J. 2004;148:222-9.
16. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937-52.